M. L. Verde

Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus.

R. Rosales, Tania Navarro, Carlos Manuel Corona Gutierrez, 2004, Human gene therapy.

Regression of papilloma high-grade lesions (CIN 2 and CIN 3) is stimulated by therapeutic vaccination with MVA E2 recombinant vaccine

R. Rosales, E. Garc, J. Gónzalez-Sánchez, 2006, Cancer Gene Therapy.